Namo Pharma

Mounjaro is FDA-approved to improve blood sugar control in adults with type 2 diabetes. It can be used alone or in combination with other diabetes medications. Weight loss is another significant effect of Mounjaro. While not all health authorities have approved it for this purpose, a related medication containing tirzepatide (Zepbound) is approved for chronic weight management in adults. Doctors may also prescribe Mounjaro off-label for weight management, particularly for those with obesity or overweight and weight-related health problems. 

Mounjaro 2.5mg Solution for Injection improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 2.5mg Solution for Injection is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg Solution for Injection. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 2.5mg Solution for Injection are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.